Breaking News

Bio Path Holdings Inc (BPTH)

NASDAQ

Add to/Remove from Watchlist Add to Watchlist

0.677 -0.033 -4.66%

15:59:59 - Closed. Currency in USD

After Hours

0.710

+0.033

+4.874%

17:15:11 - Real-time Data

Type: Equity

Market: United States

Volume: 89,565
Bid/Ask: 0.000 / 0.000
Day's Range: 0.640 - 0.756

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
- Analysis & Opinion
Financials
Technical
Forum

Bio Path Holdings Inc Company Profile

Get an in-depth profile of Bio Path Holdings Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

Equity Type

ORD

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas.

Contact Information

Address 4710 Bellaire Boulevard Suite 210
Bellaire, 77401
United States

Phone 832 742 1357

Fax -

Web www.biopathholdings.com

Top Executives

Name	Age	Since	Title
Peter H. Nielsen	74	2007	Co-Founder, Chairman of the Board, CEO, President, CFO & Treasurer
D. Craig Hooper	-	2017	Member of the Scientific Advisory Board
Douglas P. Morris	67	2007	Co-Founder, Director of Investor Relations, Secretary & Director
Jason B. Fleming	-	2018	Member of the Scientific Advisory Board
Aline B. Sherwood	53	2022	Independent Director
Heath W. Cleaver	50	2014	Independent Director
Jorge Eduardo Cortes	-	2015	Chairman of the Scientific Advisory Board
Paul D. Aubert	53	2018	Independent Director

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

BPTH Comments

Write your thoughts about Bio Path Holdings Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Tyler Philipation Feb 27, 2024 7:25PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

I blame dez nutz for the bpth Split. He’s a monster

1 0

Report

Mary Hill Jun 02, 2023 2:27PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

omg I am loading up 1

1 0

Report

Faisal Dogar Jun 02, 2023 2:27PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

0 2

Report

Haswdt Rswuntr Oct 10, 2022 4:50AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Patience is the key

2 0

Report

sarac mehmet Mar 14, 2022 11:29AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

American stocks fall and make a reverse split, and then fall again from $ 500 to $ 0.95 what does the reverse split do again There's shitty stock market.. BİO PATH a disg ra ceful stock...!!!

1 1

Report

Ec Pd Mar 14, 2022 11:29AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

lol sell!!

0 0

Report

Jose Tajes Feb 23, 2021 2:20PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

why is this the only one green now

0 0

Report

Khaled Alsarraj Feb 23, 2021 2:20PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Check OCGN

0 0

Report

Jose Tajes Feb 22, 2021 12:45PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

no thoughts on this

0 0

Report

Khaled Alsarraj Feb 22, 2021 12:45PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

I will hold I think After the FDA approvel it will 🚀🚀🚀

0 1

Report

dennis felipe Feb 12, 2021 5:25AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

just bought some on this dip....🚀🚀🚀 let's go again..

0 0

Report

Daniel Grippe Feb 11, 2021 2:12PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

where do we see this going. Got distracted and missed my exit, down 57%

0 0

Report

ArlN Feb 11, 2021 2:12PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

There might be something by the end of the month

0 0

Report

Jackson Neve Feb 10, 2021 8:29PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Even if no short squeeze to $700-800 due to its small 4 million shares float. Fundamentally, this stock will gradually move to $30-35 by 2022 after getting awarded the patent for their DNAbilize. This company really have the potential as it has hit $700-800 before. Then it has 2 stock splits 1:10 and then 1:20, so now is consider early bird accumulation phase. We will see it go above $30 by end of the week.

4 2

Report

Gregory Aizenberg Feb 10, 2021 8:29PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Saxo bank reports year average price target 10$. Company has 9 employees. Market cap. 53.5M. do you know why yesterday the price jumped onto 24$?

0 0

Report

Eugenio Basilici Feb 10, 2021 12:35PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

🔴 Breaking: $IGC a cannabis stock trading at 3$ now warming up....

0 0

Report

Frank Thrana Feb 10, 2021 12:35PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Hvis market?

0 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="216683644">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="216683644" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="216683644" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="216683644">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="207253953">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="207253953" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="207253953" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="207253953">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	44,993.8	-20.2	-0.04%
US 500	6,081.2	-5.3	-0.09%
Dow Jones	45,014.04	+308.51	+0.69%
S&P 500	6,086.49	+36.61	+0.61%
Nasdaq	19,732.87	+251.96	+1.29%
S&P 500 VIX	13.45	+0.15	+1.13%
Dollar Index	106.340	+0.010	+0.01%

Crude Oil WTI	68.75	+0.06	+0.09%
Brent Oil	72.50	+0.02	+0.03%
Natural Gas	3.072	-0.007	-0.23%
Gold	2,673.91	-0.54	-0.02%
Silver	31.852	+0.012	+0.04%
Copper	4.1993	+0.0013	+0.03%
US Soybeans	984.00	-7.00	-0.71%

U.S. 10Y	4.196	+0.014	+0.34%
U.S. 30Y	4.353	+0.004	+0.10%
U.S. 5Y	4.076	+0.012	+0.29%
U.S. 3M	4.509	+0.047	+1.05%
US 10Y T-Note	111.19	-0.06	-0.06%
Euro Bund	136.91	+0.10	+0.07%
10-2 Yield Spread	4.30	+3.52	+451.28%

Apple	243.01	+0.36	+0.15%
Alphabet A	174.37	+3.03	+1.77%
Tesla	357.93	+6.51	+1.85%
Amazon.com	218.16	+4.72	+2.21%
Netflix	911.06	+8.89	+0.99%
Meta Platforms	613.78	+0.13	+0.02%
Bank of America	46.37	-0.46	-0.97%

Recent Quotes

	Name	Price	Chg.	Chg. %
	BPTH	0.677	-0.033	-4.66%

Market Movers

Name	Last	Chg. %	Vol.
NVDA	145.14	+3.48%	215.46M
TSLA	357.93	+1.85%	46.88M
AMZN	218.16	+2.21%	46.61M
AAPL	243.01	+0.15%	38.96M
MSTR	406.00	+8.72%	27.68M
CRM	368.05	+11.05%	24.04M
MSFT	437.51	+1.46%	22.76M

Name	Last	Chg. %	Vol.
MRVL	118.16	+23.20%	56.75M
CRM	368.05	+11.05%	24.04M
TEAM	287.50	+7.13%	3.05M
DDOG	165.88	+7.01%	9.81M
NOW	1,123.13	+6.22%	2.02M
EW	74.20	+5.70%	6.07M
MDB	341.31	+5.34%	1.38M

Name	Last	Chg. %	Vol.
ANET	105.43	-74.56%	4.28M
CPB	42.69	-6.24%	6.09M
ALB	102.61	-5.92%	2.42M
MCHP	61.66	-5.70%	13.27M
ON	65.96	-5.52%	12.77M
MKTX	248.30	-5.51%	977.38K
BLDR	177.12	-3.98%	1.23M

Webinars

Invest Smarter: Investing.com Essential Tools You Must Know - December 11th Wednesday, December 11, 2024 | 10:00AM EST